Imbruvica
Imbruvica Products are primarily used for
Blood cancer (Chronic lymphocytic leukemia), Mantle-cell lymphoma
About Imbruvica Products
Uses of Imbruvica Products
Ibrutinib is used in the treatment of blood cancer (chronic lymphocytic leukemia) and mantle-cell lymphoma. It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Imbruvica Products side effects
Common
Side Effects of Imbruvica are Fever, Headache, Fatigue, Musculoskeletal (bone, muscle or joint) pain, Rash, Anemia (low number of red blood cells), Bruising, Muscle spasm, Hemorrhage, Pneumonia, Cough, Diarrhea, Stomatitis (Inflammation of the mouth), Nausea, Low blood platelets, Decreased white blood cell count (neutrophils), Dry eye, High blood pressure, Weight loss, Urinary tract infection, Peripheral edema, Subdural hematoma, Second primary malignancies.
Severe
Side Effect of Imbruvica is Tumor lysis syndrome.
How Imbruvica Products work
Ibrutinib is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Products for Imbruvica
Imbruvica 140mg Capsule
bottle of 120 capsules
MRP
₹436000
Imbruvica 140mg Capsule
bottle of 90 capsules
MRP
₹328000